Market Chameleon (Fri, 14-Aug 3:05 AM ET)
Business Wire (Fri, 14-Aug 1:00 AM ET)
Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates
Globe Newswire (Thu, 13-Aug 1:00 AM ET)
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
Globe Newswire (Wed, 22-Jul 11:45 AM ET)
Market Chameleon (Mon, 23-Mar 3:54 AM ET)
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Valneva Se - American Depositary Shares trades on the NASDAQ stock market under the symbol VALN.
As of October 1, 2026, VALN stock price declined to $5.90 with 34,363 million shares trading.
VALN has a beta of 2.10, meaning it tends to be more sensitive to market movements. VALN has a correlation of 0.13 to the broad based SPY ETF.
VALN has a market cap of $559.46 million. This is considered a Small Cap stock.
Last quarter Valneva Se - American Depositary Shares reported $41 million in Revenue and -$.40 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.12.
In the last 3 years, VALN traded as high as $14.49 and as low as $3.62.
VALN has underperformed the market in the last year with a price return of -51.6% while the SPY ETF gained +15.8%. However, in the short term, VALN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.8% vs +2.6% return in SPY. But in the last 2 weeks, VALN shares have been beat by the market, returning -10.2% compared to an SPY return of +1.6%.
VALN support price is $6.00 and resistance is $6.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VALN shares will trade within this expected range on the day.
